Primacy of cardiac chymase over angiotensin converting enzyme as an angiotensin-(1-12) metabolizing enzyme

被引:39
|
作者
Ahmad, Sarfaraz [1 ]
Varagic, Jasmina [1 ,2 ]
VonCannon, Jessica L. [2 ]
Groban, Leanne [2 ,3 ,4 ]
Collawn, James F. [7 ]
Dell'Italia, Louis J. [8 ]
Ferrario, Carlos M. [1 ,5 ,6 ]
机构
[1] Wake Forest Univ, Sch Med, Gen Surg, Winston Salem, NC 27109 USA
[2] Wake Forest Univ, Sch Med, Hypertens & Vasc Res Ctr, Winston Salem, NC 27109 USA
[3] Wake Forest Univ, Sch Med, Anesthesiol, Winston Salem, NC 27109 USA
[4] Wake Forest Univ, Sch Med, Internal Med Mol Med, Winston Salem, NC 27109 USA
[5] Wake Forest Univ, Sch Med, Internal Med Nephrol, Winston Salem, NC 27109 USA
[6] Wake Forest Univ, Sch Med, Internal Med Cardiovasc Med, Winston Salem, NC 27109 USA
[7] Univ Alabama Birmingham, Dept Cell Dev & Integrat Biol, Birmingham, AL USA
[8] Univ Alabama Birmingham, Dept Med, Div Cardiovasc Dis, Birmingham VA Med Ctr, Birmingham, AL 35294 USA
关键词
Rat cardiac chymase; Angiotensin-converting enzyme; Angiotensin-(1-12); Angiotensin I; Angiotensin II; Renin-angiotensin system; BLOOD-PRESSURE; II GENERATION; HIGH-GLUCOSE; SYSTEM; HEART; RATS; PROANGIOTENSIN-12; RECEPTOR; PEPTIDE; LOCALIZATION;
D O I
10.1016/j.bbrc.2016.07.100
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We showed previously that rat angiotensin-(1-12) [Ang-(1-12)] is metabolized by chymase and angiotensin converting enzyme (ACE) to generate Angiotensin II (Ang II). Here, we investigated the affinity of cardiac chymase and ACE enzymes for Ang-(1-12) and Angiotensin I (Ang I) substrates. Native plasma membranes (PMs) isolated from heart and lung tissues of adult spontaneously hypertensive rats (SHR) were incubated with radiolabeled I-125-Ang-(1-12) or I-125-Ang I, in the absence or presence of a chymase or ACE inhibitor (chymostatin and lisinopril, respectively). Products were quantitated by HPLC connected to an in-line flow-through gamma detector. The rate of I-125-Ang II formation from I-125-Ang-(1-12) by chymase was significantly higher (heart: 7.0 +/- 0.6 fmol/min/mg; lung: 33 +/- 1.2 fmol/min/mg, P < 0.001) when compared to I-125-Ang I substrate (heart: 0.8 +/- 0.1 fmol/min/mg; lung: 2.1 +/- 0.1 fmol/min/mg). Substrate affinity of I-125-Ang-(1-12) for rat cardiac chymase was also confirmed using excess unlabeled Ang-(1-12) or Ang I (0-250 mu M). The rate of I-125-Ang II formation was significantly lower using unlabeled Ang-(1-12) compared to unlabeled Ang I substrate. Kinetic data showed that rat chymase has a lower K-m (64 +/- 63 mu M vs 142 +/- 17 mu M), higher V-max (132 +/- 1.3 mu M/min/mg vs 1.9 +/- 0.2 mu M/min/mg) and more than 15-fold higher catalytic efficiency (ratio of V-max/K-m) for Ang-(1-12) compared to Ang I substrate, respectively. We also investigated ACE mediated hydrolysis of I-125-Ang-(1-12) and I-125-Ang I in solubilized membrane fractions of the SHR heart and lung. Interestingly, no significant difference in I-125-Ang II formation by ACE was detected using either substrate, I-125-Ang-(1-12) or I-125-Ang I, both in the heart (1.8 +/- 0.2 fmol/min/mg and 1.8 +/- 0.3 fmol/min/mg, respectively) and in the lungs (239 +/- 25 fmol/min/mg and 248 +/- 34 fmol/min/mg, respectively). Compared to chymase, ACE-mediated Ang-(1-12) metabolism in the heart was several fold lower. Overall our findings suggest that Ang-(1-12), not Ang I, is the better substrate for Ang II formation by chymase in adult rats. In addition, this confirms our previous observation that chymase (rather than ACE) is the main hydrolyzing enzyme responsible for Ang II generation from Ang-(1-12) in the adult rat heart. (C) 2016 Elsevier Inc. All rights reserved.
引用
收藏
页码:559 / 564
页数:6
相关论文
共 50 条
  • [21] Cardioprotective role for angiotensin-(1-7) and angiotensin converting enzyme 2 in the heart
    Tallant, E. Ann
    Ferrario, Carlos M.
    Gallagher, Patricia E.
    FUTURE CARDIOLOGY, 2006, 2 (03) : 335 - 342
  • [22] Role of Tissue Renin-angiotensin System and the Chymase/angiotensin-(1-12) Axis in the Pathogenesis of Diabetic Retinopathy
    Ola, Mohammad Shamsul
    Alhomida, Abdullah S.
    Ferrario, Carlos M.
    Ahmad, Sarfaraz
    CURRENT MEDICINAL CHEMISTRY, 2017, 24 (28) : 3104 - 3114
  • [23] Uptake of Novel Peptide Angiotensin-(1-12) by Cardiac Myocytes
    Ahmad, Sarfaraz
    Varagic, Jasmina
    Westwood, Brian
    Chappell, Mark C.
    Ferrario, Carlos M.
    HYPERTENSION, 2009, 54 (04) : E111 - E111
  • [24] Angiotensin-[1-12] interacts with angiotensin type I receptors
    Chan, King H.
    Chen, Yi H.
    Zhang, Ying
    Wong, Yung H.
    Dun, Nae J.
    NEUROPHARMACOLOGY, 2014, 81 : 267 - 273
  • [25] Angiotensin converting enzyme and chymase activity in the feline heart and serum
    Aramaki, Y
    Uechi, M
    Takase, K
    JOURNAL OF VETERINARY MEDICAL SCIENCE, 2003, 65 (10): : 1115 - 1118
  • [26] Mast Cell Peptidases (Carboxypeptidase A and Chymase)-Mediated Hydrolysis of Human Angiotensin-(1-12)
    Ahmad, Sarfaraz
    Wright, Kendra N.
    Varagic, Jasmina
    Groban, Leanne
    Ferrario, Carlos M.
    FASEB JOURNAL, 2019, 33
  • [27] Angiotensin Converting Enzyme 2, Angiotensin-(1-7), and Receptor Mas Axis in the Kidney
    Brant Pinheiro, Sergio Veloso
    Simoes e Silva, Ana Cristina
    INTERNATIONAL JOURNAL OF HYPERTENSION, 2012, 2012
  • [28] Human Angiotensin-(1-12) [Ang-(1-12)] is a Hypertension and Cardiac Disease Biomarker
    Ferrario, Carlos
    Groban, Leanne
    Iyer, Seethalakshmi
    Ahmad, Sarfaraz
    Wright, Kendra
    Burnett, John
    FASEB JOURNAL, 2020, 34
  • [29] Converting enzyme determines plasma clearance of angiotensin-(1-7)
    Yamada, K
    Iyer, SN
    Chappell, MC
    Ganten, D
    Ferrario, CM
    HYPERTENSION, 1998, 32 (03) : 496 - 502
  • [30] Angiotensin-(1-7) with Thioether Bridge: An Angiotensin-Converting Enzyme-Resistant, Potent Angiotensin-(1-7) Analog
    Kluskens, Leon D.
    Nelemans, S. Adriaan
    Rink, Rick
    de Vries, Louwe
    Meter-Arkema, Anita
    Wang, Yong
    Walther, Thomas
    Kuipers, Anneke
    Moll, Gert N.
    Haas, Marijke
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2009, 328 (03): : 849 - 854